1. Impact of a medical interview on the decision to switch from originator infliximab to its biosimilar in patients with inflammatory bowel disease. Issue 3 (March 2020) Authors: Haghnejad, Vincent; Le Berre, Catherine; Dominique, Yoann; Zallot, Camille; Guillemin, Francis; Peyrin-Biroulet, Laurent Journal: Digestive and liver disease Issue: Volume 52:Issue 3(2020) Page Start: 281 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗